Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETFO: Targeted Azithromycin for Trachoma Elimination
NCT03335072Phase 4Active, not recruiting
- Sponsor
- University of California, San Francisco
- Start
- Feb 2022
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of azithromycin in trachoma, sponsored by University of California, San Francisco. Started Feb 2022; status: active, not recruiting.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT03335072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335072.